Evogene Ltd 20-F for FY2024
Evogene Ltd. (EVGN)
20-F
2025-03-27
For: 2024-12-31
View Original
Added on
April 05, 2026
About this 20-F
Evogene Ltd filed this 20-F on March 27, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.51M
- up 50.9% from $5.64M a year earlier
- Net loss
- $16.49M
- compared with a net loss of $23.88M a year earlier
- Diluted EPS
- -$2.89
- compared with -$5.20 a year earlier